Literature DB >> 6145145

Characterization of the size and 5' cap of messenger RNA encoding neurophysin precursors.

C J Hough, I M Chaiken.   

Abstract

The coding activity of bovine hypothalamic poly A+ mRNA for neurophysin I and II immunoreactive proteins was characterized with respect to size and 5' cap. The mRNA was fractionated by methylmercuric hydroxide agarose gel electrophoresis and subsequently translated in vitro in rabbit reticulocyte lysates. Alternatively, mRNA was fractionated by gel exclusion HPLC and translated in wheat germ extracts. Immunoprecipitated translation products were analyzed by gel exclusion HPLC. Neurophysin-immunospecific protein of approximately 17,000 daltons, the size expected for the neuropeptide hormone-neurophysin precursors, was encoded by mRNA species of two size classes. The smaller class of mRNA's was of the size expected from the size of the precursor proteins. The larger class was 5-10 times larger. The low K+ concentration optimum for translation of unfractionated mRNA encoding neurophysin I immunoreactive proteins and the inability of a cap analogue to inhibit this translation suggest that mRNA species encoding neurophysin I-immunoreactive translation products are incompletely capped. By contrast, the mRNA encoding neurophysin II-immunoreactive products appear to contain a normal cap structure.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6145145      PMCID: PMC318840          DOI: 10.1093/nar/12.10.4397

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  25 in total

1.  Methylmercury as a reversible denaturing agent for agarose gel electrophoresis.

Authors:  J M Bailey; N Davidson
Journal:  Anal Biochem       Date:  1976-01       Impact factor: 3.365

2.  Influence of potassium salt concentration and temperature on inhibition of mRNA translation by 7-methylguanosine5'-monophosphate.

Authors:  L A Weber; E D Hickey; C Baglioni
Journal:  J Biol Chem       Date:  1978-01-10       Impact factor: 5.157

3.  Competitive mRNA translation in an in vitro system from wheat germ.

Authors:  D Herson; A Schmidt; S Seal; A Marcus; L van Vloten-Doting
Journal:  J Biol Chem       Date:  1979-09-10       Impact factor: 5.157

4.  Preparation of biologically active conjugates of bovine neurophysins and other polypeptides with multi-(poly-D,L-alanyl)--poly-L-lysine and their use to elicit antibodies.

Authors:  E A Fischer; J G Curd; I M Chaiken
Journal:  Immunochemistry       Date:  1977-08

5.  Synthesis, transport, and release of posterior pituitary hormones.

Authors:  M J Brownstein; J T Russell; H Gainer
Journal:  Science       Date:  1980-01-25       Impact factor: 47.728

6.  Cell-free translation of bovine hypothalamic mRNA. Synthesis and processing of the prepro-neurophysin I and II.

Authors:  H Schmale; B Leipold; D Richter
Journal:  FEBS Lett       Date:  1979-12-15       Impact factor: 4.124

7.  Methylmercury hydroxide enhancement of translation and transcription of ovalbumin and conalbumin mRNA's.

Authors:  F Payvar; R T Schimke
Journal:  J Biol Chem       Date:  1979-08-25       Impact factor: 5.157

8.  Cell-free biosynthesis of different high molecular weight forms of bovine neurophysins I and II coded by hypothalamic mRNA.

Authors:  L C Giudice; I M Chaiken
Journal:  J Biol Chem       Date:  1979-12-10       Impact factor: 5.157

9.  Immunological and chemical identification of a neurophysin-containing protein coded by messenger RNA from bovine hypothalamus.

Authors:  L C Giudice; I M Chaiken
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

10.  Immunological identification of high molecular weight forms common to bovine neurophysin and vasopressin.

Authors:  P Nicolas; M Camier; M Lauber; M J Masse; J Möhring; P Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

View more
  1 in total

Review 1.  Genetic predisposition for multiple myeloma.

Authors:  Maroulio Pertesi; Molly Went; Markus Hansson; Kari Hemminki; Richard S Houlston; Björn Nilsson
Journal:  Leukemia       Date:  2020-01-08       Impact factor: 11.528

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.